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Summary  Nitric  oxide  (NO)  is  a  free  radical  which  is  produced  from  a  wide  variety  of  cells  and
tissues in  the  human  body.  NO  is  involved  in  the  regulation  of  many  physiological  processes,  such
as vascular  relaxation,  neurotransmission,  immune  regulation,  and  cell  death.  NO  is  generated
by nitric  oxide  synthase  (NOS),  which  has  three  identiﬁed  isoforms:  neuronal  type  NOS  (nNOS),
endothelial  type  NOS  (eNOS),  and  inducible  type  NOS  (iNOS).  Different  isoforms  are  expressed
depending  on  the  organs,  tissues,  and  cells,  and  investigation  of  the  types  and  functions  of
enzymes expressed  in  various  tissues  is  underway.  The  oral  cavity  is  a  space  in  which  marked
changes have  been  detected  in  NO  levels,  and  each  tissue  is  constantly  inﬂuenced  by  NO.  NO  is
a component  of  saliva  and  is  produced  by  oral  bacteria  in  the  oral  cavity  and  released  by  NOS
expressed  in  oral  mucosa.  NOS  isoforms  expressed  under  normal  conditions  differ  among  the
oral organs.  In  addition,  the  overexpression  of  NOS  was  involved  in  carcinogenesis  and  tumor
growth progression.  This  review  summarized  the  expression  of  NOS  and  functions  of  NO  in  oral
cavity organs,  and  their  roles  in  diseases  and  the  inﬂuences  of  treatments.
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1. Introduction
Nitric  oxide  (NO)  is  a  short-lived  free  radical  with  an
unpaired  electron.  Although  a  factor  released  by  vascular
endothelial  cells  that  relaxes  the  surrounding  smooth  mus-
cle  cells  was  initially  termed  endothelium-derived  relaxing
factor  (EDRF),  Murad  F,  Ignarro  LJ,  and  Furchgott  RF  dis-
covered  in  1987  that  EDRF  was  NO.  NO  is  a  tasteless  and
odorless  gas  that  is  capable  of  penetrating  the  cell  mem-
brane,  and  exerts  its  effects  without  the  use  of  a  receptor,
thereby  representing  a  new  signaling  pathway  for  intercel-
lular  communication.  The  Nobel  Prize  was  awarded  to  Murad
F,  Ignarro  LJ,  and  Furchgott  RF  for  the  discovery  that  NO  is  a
signaling  molecule  (1998).  Since  NO  is  a  gas,  difﬁculties  were
associated  with  determining  its  localization  and  production
in  the  body;  however,  the  discovery  of  nitric  oxide  synthase
(NOS),  which  plays  a  role  in  the  synthesis  of  NO  from  L-
arginine,  accelerated  understanding  on  the  expression  and
function  of  NOS  in  the  body.  Using  puriﬁcation  and  cloning
methods,  3  NOS  isoforms  have  been  identiﬁed  to  date:  nNOS,
iNOS,  and  eNOS  [1].  NO  is  actively  synthesized  in  the  brain,
and  the  neuronal  NOS  isoform  (nNOS  or  NOS1)  was  initially
cloned  from  the  rat  brain  [2,3].  The  inducible  NOS  isoform
(iNOS  or  NOS2)  induced  by  LPS  and  various  cytokines  (IL-1,
TNF-,  and  IFN-) was  cloned  from  macrophages  [4], while
the  endothelial  NOS  isoform  (eNOS  or  NOS3)  was  cloned  from
vascular  endothelial  cells  [5].
The  component  proteins  of  the  body  are  nitrosylated
by  NO  [6,7],  and  the  biotin-switch  assay  is  used  as  a  sim-
ple  method  to  measure  nitrosylated  protein  levels  [8].
The  production  and  functions  of  NO  have  been  exten-
sively  examined  using  morphological  investigations  of  NOS
and  the  biotin-switch  assay,  and  the  presence  of  NOS-
expressing  cells  in  various  tissues  and  organs  has  been
conﬁrmed,  thereby  demonstrating  the  diversity  of  the  func-
tions  of  NO.  NO  has  also  been  implicated  in  various  diseases.
The  physiological  and  pathological  roles  of  NO  are  known
to  be  involved  include  vasodilatation,  platelet  aggrega-
tion,  immune  responses,  cell  migration,  neurotransmission,
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poptosis,  wound  healing,  and  carcinogenesis.  The  functions
f  NO  may  differ  depending  on  the  state  of  cells.  For  exam-
le,  NO  produced  by  nNOS,  which  is  expressed  by  nerve  cells,
as  been  shown  to  promote  nerve  cell  death  in  Parkinson’s
isease  [9].  In  contrast,  NO  has  been  suggested  to  induce
he  expression  of  brain-derived  neurotrophic  factor  (BDNF)
nder  normal  conditions  and  promote  nerve  cell  survival
10]. NO  is  also  involved  in  apoptosis  in  the  developmental
tage,  but  inhibits  cell  death  by  suppressing  the  expression
f  Fas  [11,12], thereby  showing  the  dual  functions  of  NO
n  cells.  The  NOS  isoform  expressed  differs  depending  on
he  cellular  condition.  Previous  studies  using  NOS  KO  mice
emonstrated  that  the  isoform  not  normally  expressed  is
ompensatory  expressed  in  KO  mice  [13].
The  expression  of  NOS  has  been  detected  in  all  types
f  cells,  and  the  diverse  functions  of  the  NO  produced
ave  been  investigated  using  various  methods.  The  recently
eported  expression  of  NOS  and  functions  of  NO  in  oral  cav-
ty  organs,  and  their  roles  in  diseases  and  the  inﬂuences  of
reatments,  were  herein  reviewed.
.  NO in dental pulp
.1.  NOS  expression  in  dental  pulp
egarding  NOS  in  human  dental  pulp,  nNOS  and  eNOS  are
nown  to  be  expressed  in  odontoblasts,  whereas  iNOS  is
ot  under  normal  conditions  [14—16].  The  function  of  NO
roduced  by  nNOS  and  eNOS  expressed  in  odontoblasts  was
xamined,  and  its  involvement  in  the  transmission  of  pain
timulation  has  been  suggested  [14]. In  addition  to  odon-
oblasts,  eNOS  was  also  found  to  be  expressed  in  vascular
ndothelial  cells  and  ﬁbroblasts  (Fig.  1) [14—16]. NO  pro-
uced  by  eNOS  in  vascular  endothelial  cells  was  suggested
o  be  involved  in  vascular  dilation,  which  is  similar  to  that  in
any  other  tissues  [16—18]. In  previous  studies  using  cats,
he  expression  of  NOS  was  detected  in  nerve  ﬁbers,  suggest-
ng  that  the  NO  is  involved  in  sensation  of  the  dental  pulp
16  
Figure  1  Immunostaining  of  the  mouse  dental  pulp  of  lower
ﬁrst molar  at  10  weeks  of  age  with  anti-eNOS  antibody.  Some
ﬁbroblasts  (arrow)  and  the  blood  vessels  (arrowhead)  are  posi-
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in  the  expression  of  iNOS  and  production  of  NO  [29].ive in  the  dental  pulp.  Bar,  50  m.
nd  regulation  of  blood  ﬂow,  and  the  regulation  of  blood
ow  by  NO  has  been  demonstrated  [19].
.2.  Disease  and  treatment  of  dental  pulp  and  NO
lthough  absent  in  healthy  dental  pulp,  RT-PCR  and  West-
rn  blotting  revealed  the  expression  of  iNOS  at  the  mRNA
nd  protein  levels  with  acute  inﬂammation  in  dental  pulp
15].  This  iNOS  is  considered  to  be  derived  from  white  blood
ells  that  migrate  from  blood  vessels  in  response  to  pulpitis
15].  Fan  et  al.  [20]  exposed  dental  pulp  in  order  to  induce
hronic  tooth  inﬂammation  in  rats,  examined  the  role  of  NOS
n  the  trigeminal  ganglion  and  trigeminal  nucleus  caudalis,
nd  found  that  NO  and  NOS  were  crucially  involved  in  both
eripheral  and  central  nociceptive  information.
Although  slightly  different  from  its  expression  in  dental
ulp  diseases,  the  expression  of  NO  was  shown  to  be  induced
y  tooth  preparation  in  the  treatment  of  dental  caries
21—23];  a  large  amount  of  NO  was  released  by  odontoblasts
nd  dental  pulp  cells  below  the  cavity  early  after  tooth
reparation  [23].  This  NO  was  produced  by  iNOS  [21—23].
he  large  amount  of  NO  produced  by  this  iNOS  was  immedi-
tely  released  after  tooth  preparation  and  mainly  induced
poptosis  in  odontoblasts,  and  the  involvement  of  NO  in  reg-
lating  the  subsequent  differentiation  of  odontoblasts  was
uggested  [23].  Odontoblasts  then  form  a  tertiary  dentin,
nd  the  involvement  of  NO  in  this  mineralization  process
as  also  been  suggested  [23].  Therefore,  NO  produced  in  the
ental  pulp  plays  roles  in  diverse  events,  such  as  the  induc-
ion  of  apoptosis  in  odontoblasts,  promotion  of  proliferation
nd  differentiation  of  undifferentiated  mesenchymal  cells,
nd  mineralization  of  tertiary  dentin  by  newly  differenti-
ted  odontoblasts.eNOS  is  expressed  in  normal  dental  pulp,
hile  iNOS  is  expressed  in  diseased  and  treated  dental  pulp
the  level  and  range  of  expression  vary  depending  on  the
isease  and  content  of  the  treatment).  These  differences  in
he  expression  of  NOS  prompted  the  condition  of  dental  pulp
o  be  evaluated  based  on  NOS  expression.  For  example,  the
nﬂuences  of  light-emitting  diode  (LED)  irradiation  [24]  and
o
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 pulp-capping  material,  mineral  trioxide  aggregate  (MTA)
25], on  dental  pulp  have  been  reported.
. NO in periodontal tissue
.1.  NOS  expression  in  periodontal  tissue
he  expression  of  NOS  in  periodontal  tissue  has  been  inves-
igated  using  laboratory  animals  (mainly  rats)  [26—28],  but
ot  humans.  These  studies  demonstrated  that  NOS  was
xpressed  in  ﬁbroblasts,  the  epithelial  cell  rests  of  Malassez,
acrophages,  osteoclasts,  and  vascular  endothelial  cells  in
he  rat  periodontal  ligament  [26—28].  The  epithelial  cell
ests  of  Malassez  have  been  examined  extensively,  with  the
xpression  of  nNOS  and  eNOS  being  detected,  whereas  that
f  iNOS  varied  [28].  An  in  vitro  study  reported  that  the
pithelial  cell  rests  of  Malassez  of  humans  was  expressed
NOS  [29]. NO  produced  by  nNOS  and  eNOS  expressed  in  the
pithelial  cell  rests  of  Malassez  has  been  suggested  to  pro-
ote  cell  proliferation,  differentiation,  and  apoptosis  [28],
hereas  that  produced  by  ﬁbroblasts  may  play  a  role  in  the
ifferentiation  of  osteoblasts  via  the  mitogen-activated  pro-
ein  kinase  and  nuclear  factor-kappaB  pathways  present  in
uman  periodontal  ligament  ﬁbroblasts  in  vitro  [30].  Reac-
ive  oxygen,  a  kind  of  free  radical,  has  been  reported  to  be
ssociated  with  differentiation  of  osteoblasts  as  well  as  NO
31]. NO  produced  by  eNOS  in  vascular  endothelial  cells  has
een  suggested  to  be  involved  in  vascular  dilation,  similar  to
hat  produced  by  vascular  endothelial  cells  in  various  tissues
18].
On  the  other  hand,  the  gingival  expression  of  NOS  has
een  reported  in  the  basal  cells  of  the  gingival  epithelium,
broblasts,  and  vascular  endothelial  cells  of  the  gingival
amina  propria  [13].  Although  few  studies  have  examined
he  role  of  NO  in  normal  gingiva,  the  expression  of  NOS
nd  production  of  NO  have  been  suggested.  It  has  also  been
eported  that  no  abnormality  existed  in  the  phenotype  of
NOS  knockout  animals,  and  the  expression  of  eNOS  and
NOS  was  enhanced  in  the  gingival  lamina  propria,  resulting
n  no  changes  to  NO  levels  [13].  NOS  expressed  in  vascular
ndothelial  cells  have  been  shown  to  regulate  blood  ﬂow
18].
.2.  Periodontal  disease  and  NO
 large  number  of  studies  have  examined  the  various  dis-
ases  of  periodontal  tissue.  iNOS  expression  levels  were
reviously  reported  to  be  markedly  higher  in  human  peri-
dontal  disease  tissue  than  in  healthy  periodontal  tissue
32]. This  iNOS  was  considered  to  be  derived  from  white
lood  cells  that  migrated  to  the  lesion;  however,  studies
sing  human  periodontal  ligament  ﬁbroblasts  showed  that
he  addition  of  LPS  enhanced  the  expression  of  iNOS  in
broblasts  and  increased  NO  production  [29]. Therefore,  in
ddition  to  migrating  white  blood  cells,  ﬁbroblasts  inﬂu-
nced  by  various  cytokines  were  suggested  to  be  involved
n  the  periodontal  disease-induced  enhancements  observedAlveolar  bone  resorption  occurs  with  the  progression
f  periodontal  disease  (marginal  periodontitis).  It  has  also
een  reported  in  the  root  apex  in  apical  periodontitis,
17
Figure  2  Expression  of  eNOS  mRNA  in  the  mouse  lower  incisor
at 8  weeks  of  age  by  in  situ  hybridization.  eNOS  signals  are
detected  in  ameloblasts  (arrow)  at  the  maturation  stage  (aster-
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The  gustatory  receptors,  taste  buds,  are  present  in  the
lingual  mucosa.  The  expression  of  NOS  has  been  reported  inNO  in  the  oral  cavity  
and  the  involvement  of  NO  in  these  bone  resorption  pro-
cesses  has  been  reported  [33,34].  Alveolar  bone  resorption
in  marginal  periodontitis  was  prevented  in  rats  by  inhibiting
the  expression  of  NOS  [33],  and  the  induction  of  multinucle-
ated  TRAP-positive  cells  through  the  production  of  NO  has
been  reported  in  apical  periodontitis  [34].  Previous  studies
on  the  relationship  between  osteoclasts  and  NO  in  bone  tis-
sue  suggested  that  NO  played  an  important  role  in  osteoclast
differentiation  [35,36].  Regarding  the  mechanism  underly-
ing  periodontal  disease-induced  alveolar  bone  resorption,
osteoclast  differentiation  may  have  been  promoted  by  the
NO  produced  by  migrating  white  blood  cells  and  ﬁbroblasts,
and  these  osteoclasts  may  have  resorbed  bone.
Periodontal  disease  reduces  occlusal  force  in  patients
who  lose  a  tooth  and  also  in  the  elderly.  The  dynamics  of
NOS  were  examined  in  relation  to  the  expression  of  NOS  in
a  hypofunctional  periodontal  ligament  and  during  its  func-
tional  recovery  process;  when  occlusal  force  decreased,  NOS
expression  decreased  in  the  periodontal  ligament  [37].  This
reduction  in  reactivity  was  attributed  to  changes  in  the
NOS-positive  region  in  the  periodontal  ligament,  rather  than
reductions  in  the  number  of  NOS-positive  cells.  In  addi-
tion,  the  expression  of  NOS  was  enhanced  with  the  recovery
of  occlusal  force.  Furthermore,  the  expression  of  NOS  was
found  to  be  enhanced  when  occlusal  force  was  higher  than
that  in  the  normal  state.  These  ﬁndings  suggested  that  NO
was  important  for  the  structural  changes  to  the  periodontal
ligament  induced  by  an  increase  in  occlusal  force  [37].
4. NOS expression induced by orthodontic
treatments
Previous  studies  have  extensively  examined  orthodontic
tooth  movement-induced  NOS  expression,  and  this  may  have
been  based  on  the  reported  ﬁndings  [38—42]  that  many
cells  in  periodontal  tissue,  mainly  the  periodontal  ligament,
express  NOS  under  normal  conditions,  and  NO  is  involved  in
various  functions,  as  described  above.
Rat  molars  have  been  used  in  many  studies  that  morpho-
logically  investigated  the  relationship  between  orthodontic
treatments  and  NOS  [38—40].  These  studies  demonstrated
that  the  expression  of  NOS  differed  between  tension  and
compression  areas  (pressure  side).  The  expression  of  NOS
in  bone  tissue  has  been  attracting  attention.  When  an
orthodontic  force  (10  cN  for  120  h)  was  loaded  on  the  tension
area  (side)  of  alveolar  bone,  the  number  of  eNOS-positive
osteocytes  started  to  increase  after  24  h,  and  a  small  number
of  iNOS-positive  osteocytes  were  also  found  to  be  present.  In
contrast,  the  number  of  iNOS-positive  osteocytes  in  the  com-
pression  area  (pressure  side)  started  to  increase  6  h  after
loading  the  force,  and  that  of  eNOS-positive  osteocytes  also
increased  from  24  h.  These  ﬁndings  suggested  that  osteo-
cytes  functioned  as  a  regulator  in  tension  and  compression
areas  (pressure  side),  i.e.,  eNOS  expressed  by  osteocytes
in  the  tension  area  (side)  acted  as  a  regulator  of  bone
formation  while  iNOS  expressed  in  the  compression  area
(pressure  side)  acted  as  a  regulator  of  inﬂammation-induced
bone  resorption  [39].  Another  study  [40]  demonstrated  that
these  actions  as  a  mechanosensor  in  the  tension  (side)  and
compression  (pressure  side)  areas  were  performed  by  peri-
odontal  ligament  ﬁbroblasts,  not  osteocytes.
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Orthodontic  treatment-induced  NOS  expression  in  the
ingiva  [41]  and  dental  pulp  [42]  has  also  been  reported,
nd  the  expression  of  eNOS  and  iNOS  in  both  these  tissues
as  shown  to  be  signiﬁcantly  higher  than  that  under  normal
onditions.
.  NOS expression in odontogenesis
ew  studies  have  investigated  the  role  of  NOS  expression
n  odontogenesis.  A  neonatal  mouse  tooth  germ  was  cul-
ured  and  the  inﬂuence  of  NO  was  investigated,  and  the
ndings  obtained  suggested  that  a  NO  signaling  pathway  was
artially  involved  in  the  amelogenin  production  process  in
meloblasts  [43]. Our  group  also  investigated  the  function
nd  expression  of  NOS  in  ameloblasts  at  the  protein  and
RNA  levels  using  a  mouse  tooth  germ.  We  conﬁrmed  the
RNA  expression  of  iNOS  and  eNOS  in  ameloblasts  in  the
aturation  stage  using  in  situ  hybridization,  showing  that
O  was  produced  by  iNOS  and  eNOS  in  maturation-stage
meloblasts  (Fig.  2).  The  function  of  this  NO  is  now  being
nvestigated.  We  assume  that  it  is  involved  in  secondary
alciﬁcation  and  protein  removal  by  ameloblasts.
.  NOS expression in the tongue
 limited  number  of  studies  have  investigated  the  expression
f  NOS  in  the  tongue;  however,  eNOS  was  previously  shown
o  be  expressed  in  blood  vessels  distributed  in  the  tongue,
hile  NO  regulated  blood  ﬂow  [18].hese  taste  buds  [44]:  the  expression  of  nNOS  was  detected
n  taste  cells  and  the  surrounding  nerve  ﬁbers,  suggesting
hat  NO  is  involved  in  the  transmission  of  gustatory  signals.
owever,  this  study  only  examined  Amphibia,  not  humans.
18  
Figure  3  Immunostaining  of  the  mouse  sublingual  gland  at  10
weeks of  age  with  anti-nNOS  antibody.  nNOS-positive  reactions
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ing  its  involvement  and  the  pathology  associated  with  NOppears  in  the  striated  ducts  (arrowhead),  but  the  acini  are
egative.  Bar,  50  m.
. NO in the salivary gland
.1.  NOS  expression  in  the  salivary  gland
he  expression  of  nNOS  has  been  reported  in  nerve  ﬁbers  dis-
ributed  in  the  acini,  and  these  nNOS-positive  nerve  ﬁbers
ere  found  to  be  synaptically  connected  to  acinar  cells.
any  previous  studies  reported  these  ﬁndings,  suggesting
he  production  of  NO  in  the  acini  [45,46].  The  function  of
his  NO  has  been  examined  from  various  viewpoints.  Acinar
ells  are  double-innervated  by  autonomic  sympathetic  and
arasympathetic  nerves.  The  expression  of  nNOS  has  been
etected  in  both  sympathetic  and  parasympathetic  nerves.
n  parasympathetic  nerves,  NO  produced  by  nNOS  enhances
he  release  of  H2O  and  ions  through  muscarinic  receptors
n  acinar  cells  [47,48].  NO  has  also  been  reported  to  act
n  acinar  cells  and  induce  amylase  secretion  in  sympathetic
erves  [48,49].
NO  produced  by  nNOS  is  known  to  act  on  ion  channels  of
cinar  cells,  and,  is  crucially  involved  in  Ca2+ release  [47].
he  production  of  NO  in  the  acini  is  considered  to  occur  in
erve  ﬁbers  distributed  to  acinar  cells  and  contributes  to
aliva  secretions  including  ions,  as  described  above;  how-
ver,  NO  has  recently  been  suggested  to  be  involved  in
rotein  synthesis  in  and  the  division  of  acinar  cells  [49].
n  the  other  hand,  the  expression  of  NOS  has  also  been
bserved  in  the  ductal  system,  other  than  the  acini.  Our
roup  conﬁrmed  the  expression  of  nNOS  in  the  ductal  system
Fig.  3).  Although  the  function  of  NOS  in  the  ductal  system
urrently  remains  unclear,  it  has  been  suggested  to  play  a
ole  in  regulating  saliva  secretions  and  the  direct  secretion
f  NO  into  saliva  [45,50].
The  studies  on  the  expression  and  functions  of  NOS  in  the
alivary  gland  described  above  used  the  rat  parotid  gland
46—48].  Salivary  gland  tissue  is  known  to  markedly  vary
mong  animal  species,  with  its  histological  structure  and
omposition  of  secretions  being  diverse,  and  functions  also
iffering.  Species  differences  have  also  been  reported  in  the
xpression  of  NOS.  Previous  studies  [45]  compared  the  sali-
ary  gland  between  humans  and  rats,  and  found  that  the
h
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umber  of  nNOS-positive  nerves  was  lower  while  the  num-
er  of  ductal  cells  expressing  nNOS  was  higher  in  the  rat
alivary  gland  than  in  the  human  salivary  gland.  Functional
ifferences  due  to  differences  in  the  region  of  the  salivary
land  expressing  NOS  between  humans  and  rats  remain  to
e  investigated  in  future  studies.
.2.  Salivary  gland  disease  and  NO
he  excess  production  of  NO  in  the  salivary  gland  has  been
mplicated  in  the  development  of  various  diseases.  NO-
elated  diseases  of  the  salivary  gland  are  characterized  by
he  overexpression  of  NOS  in  acinar  cells,  in  which  it  is
ot  expressed  under  normal  conditions,  unlike  other  tissues.
jögren’s  syndrome  is  a  representative  NO-related  disease,
nd  the  relationship  between  its  pathology  and  the  expres-
ion  of  NO  and  NOS  has  been  closely  investigated  [51—53].
jögren’s  syndrome  is  an  autoimmune  disease,  in  which
-cells  secrete  various  cytokines  that  damage  or  induce  apo-
tosis  in  acinar  cells,  leading  to  the  symptoms  of  the  disease,
uch  as  acinar  atrophy  and  hypofunction  of  the  salivary
land.  The  involvement  of  NO  in  this  acinar  cell  hypofunc-
ion  has  been  reported.  NO  is  not  secreted  by  inﬂammatory
ells,  such  as  T-cells  (not  necessarily  indicating  the  complete
bsence  of  secretion),  and  acinar  cells  produce  NO  by  them-
elves,  i.e.,  acinar  cells  express  iNOS  and  produce  NO,  which
hen  nitrosylates  various  signaling  pathways  in  acinar  cells,
esulting  in  acinar  cell  hypofunction.  This  NO-mediated  aci-
ar  cell  hypofunction  has  been  suggested  to  be  a  cause  of
jögren’s  syndrome  [51—53].
.3.  NO  in saliva
itrate  is  secreted  into  the  oral  cavity  as  a  saliva  compo-
ent  in  humans.  This  nitrate  is  converted  to  NO  rapidly  by
ral  bacteria  and  more  slowly  by  salivary  peroxidase  [54].
ental  plaque  deposition  has  been  shown  to  increase  NO
evels  in  the  oral  cavity,  and  this  has  been  attributed  to  the
elease  of  NO  by  the  host  defense  mechanism  in  an  attempt
o  prevent  the  proliferation  of  bacteria  in  dental  plaques
55]. Elevations  in  NO  levels  in  the  oral  cavity  and  saliva
ue  to  various  causes  have  been  associated  with  oral  dis-
ases.  A  previous  study  [56]  using  the  saliva  of  oral  cancer
atients  showed  that  salivary  NO  levels  were  signiﬁcantly
igher  in  the  saliva  of  patients  than  in  that  of  healthy  sub-
ects,  suggesting  that  the  measurement  of  salivary  NO  levels
s  applicable  for  the  diagnosis  and  treatment  of  oral  cancer.
 high  salivary  NO  level  has  also  been  reported  in  children
ith  rampant  caries  and  early  childhood  caries  [57].  The
elationship  between  salivary  NO  levels  and  various  diseases
eeds  to  be  investigated  in  more  detail  in  future  studies.
. NOS expression in oral cancer
lthough  NO  is  known  to  play  a  role  in  carcinogenesis  and
umor  growth  progression  [58],  the  mechanisms  underly-ave  not  yet  been  elucidated  in  detail.  This  may  be  because
ancers  arise  from  various  tissues  through  different  mech-
nisms,  and  exogenous  factors  affecting  each  tissue  are
CT
R
[
[
[
[
[
[
[
[
[NO  in  the  oral  cavity  
different  among  tissues.  Studies  on  the  relationship  between
cancers  arising  in  the  oral  cavity  and  NO  have  been  actively
performed  because  of  many  mechanical  stimuli,  the  pres-
ence  of  high  levels  of  NO  in  saliva  [58—62].  Oral  squamous
cell  carcinomas  (OSCC)  [60—62]  have  been  investigated  in
many  of  these  studies,  in  which  the  expression  of  iNOS  was
not  detected  in  the  oral  epithelium  under  normal  conditions,
but  was  markedly  higher  at  the  protein  and  mRNA  levels  in
OSCC  [60].  The  relationship  between  the  expression  of  this
iNOS  and  oral  epithelial  transformation  as  well  as  tumor
formation  and  development  has  been  suggested  in  a  large
number  of  previous  studies  [60—62].  The  expression  of  eNOS
and  VEGF  has  also  been  observed  in  OSCC,  suggesting  that
the  production  of  NO  is  involved  in  angiogenesis  [63,64].  NOS
has  been  implicated  in  the  development  of  OSCC.  OSCC  is
induced  by  NO  produced  by  iNOS,  and  NO  produced  by  eNOS
is  involved  in  cancer  growth  through  angiogenesis.
However,  a  previous  study  overexpressed  iNOS  in  vitro,
and  showed  that  NO  caused  the  accumulation  of  p53  and
induced  apoptosis  in  cancer  cells  [65].  In  another  study  using
RNAi  (tongue  squamous  cell  carcinoma  cells),  the  inhibi-
tion  of  iNOS  gene  expression  was  found  to  suppress  cell
proliferation  and  induced  apoptosis  [66].  The  inhibition  of
tumorigenicity  through  the  overexpression  of  iNOS  has  also
been  reported  [67],  but  only  in  vitro. This  tumor-inhibitory
effect  of  NO  has  not  yet  been  demonstrated  in  vivo.
The  expression  of  iNOS  has  also  been  reported  in  oral  dys-
plasia  [60]  and  oral  lichen  planus  [68].  When  the  expression
of  iNOS  was  compared,  it  was  found  to  be  higher  in  the  2
diseases  than  in  normal  tissue,  but  lower  than  that  in  OSCC
in  a  previously  reported  study  [60,68].  The  expression  of
iNOS  leads  to  the  production  of  NO,  which,  in  turn,  induces
the  development  of  oral  dysplasia  and  oral  lichen  planus.  If
the  expression  of  iNOS  increases  thereafter,  DNA  damage  by
NO  increases  and  may  induce  the  development  of  oral  can-
cer  [60,68].  The  relationship  between  ameloblastomas  and
the  expression  of  NOS  has  also  been  investigated,  and  an
association  between  the  activation  of  iNOS  and  malignant
potential  has  been  suggested  [69].
9. Conclusion
As  described  above,  NOS  expressed  under  normal  conditions
differs  among  the  oral  organs,  and  the  NO  produced  has
diverse  functions.  However,  the  expression  and  functions  of
NOS,  including  those  in  odontogenesis  and  tongue  and  peri-
odontal  tissues,  have  not  yet  been  sufﬁciently  investigated.
Furthermore,  the  relationship  between  the  expression  of
NOS  and  NO  in  various  oral  diseases  remains  unclear,  and
the  production  of  and  pathology  associated  with  NO  have
only  been  partially  elucidated.  The  application  of  mea-
suring  salivary  NO  levels  for  diagnoses  and  treatments  is
currently  being  investigated.  NO  is  a  component  of  saliva
and  is  produced  by  oral  bacteria  in  the  oral  cavity.  It  is  also
produced  and  released  by  NOS  expressed  in  oral  mucosa,
such  as  gingiva.  The  oral  cavity  is  a  space  in  which  marked
changes  have  been  detected  in  NO  levels,  and  each  tis-
sue  is  constantly  inﬂuenced  by  NO.  NO  is  closely  associated
with  the  oral  cavity,  and  the  progression  of  its  analy-
sis  through  the  application  of  various  research  methods  is
expected.
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